Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NanoVibronix ( (NAOV) ) just unveiled an announcement.
On September 16, 2025, NanoVibronix entered into a securities purchase agreement with an institutional investor to issue and sell shares and prefunded warrants in a registered direct offering, raising approximately $1.8 million in net proceeds. The company plans to use these funds for general working capital, including debt repayment and preferred stock redemption, potentially impacting its financial stability and market positioning.
More about NanoVibronix
NanoVibronix, Inc. is a medical technology company specializing in non-invasive therapeutic systems, headquartered in Tyler, Texas, with R&D in Nesher, Israel. The company focuses on acoustic-based therapeutic technologies like PainShield® and UroShield®, and the ENvue™ Navigation Platform, which assists in minimally invasive procedures.
Average Trading Volume: 1,062,160
Technical Sentiment Signal: Sell
Current Market Cap: $8.53M
For detailed information about NAOV stock, go to TipRanks’ Stock Analysis page.